1 January–31 December
|
kEUR |
2024 |
2023 |
|
|
|
|
|
|
|
Result for the year |
|
-19,564 |
-51,440 |
|
|
|
|
|
|
Other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Exchange differences on translation of foreign operations, net of tax |
|
-523 |
7,713 |
|
Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
|
-523 |
7,713 |
|
|
|
|
|
|
Other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
|
|
|
Remeasurement gain / (loss) on defined benefit plans |
-6,490 |
3,269 |
|
|
Income tax effect |
1,392 |
-836 |
|
|
Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
|
-5,098 |
2,433 |
|
Other comprehensive result for the year, net of taxes |
|
-5,621 |
10,146 |
|
|
|
|
|
|
Total comprehensive result for the year, net of taxes |
|
-25,185 |
-41,294 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
-25,185 |
-41,294 |